These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20038189)

  • 1. Considering the value associated with innovation in health technology appraisal decisions (deliberations): a NICE thing to do?
    Green C
    Appl Health Econ Health Policy; 2010; 8(1):1-5. PubMed ID: 20038189
    [No Abstract]   [Full Text] [Related]  

  • 2. NICE and new: appraising innovation.
    Ferner RE; Hughes DA; Aronson JK
    BMJ; 2010 Jan; 340():b5493. PubMed ID: 20051468
    [No Abstract]   [Full Text] [Related]  

  • 3. On being NICE in the UK: guidelines for technology appraisal for the NHS in England and Wales.
    Birch S; Gafni A
    Health Econ; 2002 Apr; 11(3):185-91. PubMed ID: 11921316
    [No Abstract]   [Full Text] [Related]  

  • 4. Searching for a threshold - Not so NICE..
    Mooney G; Coast J; Jan S; ; Ryan M; Wiseman V
    J Health Serv Res Policy; 2007 Jul; 12(3):190; author reply 190-1. PubMed ID: 17716427
    [No Abstract]   [Full Text] [Related]  

  • 5. Seeing the NICE side of cost-effectiveness analysis: a qualitative investigation of the use of CEA in NICE technology appraisals.
    Bryan S; Williams I; McIver S
    Health Econ; 2007 Feb; 16(2):179-93. PubMed ID: 16960851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the technology strategy board?
    Latif Z
    Health Serv J; 2012 Nov; 122(6327):26. PubMed ID: 23323490
    [No Abstract]   [Full Text] [Related]  

  • 7. Valuing health technologies at NICE: recommendations for improved incorporation of treatment value in HTA.
    Goldman D; Lakdawalla D; Philipson TJ; Yin W
    Health Econ; 2010 Oct; 19(10):1109-16. PubMed ID: 20842680
    [No Abstract]   [Full Text] [Related]  

  • 8. Quality, innovation, and value for money: NICE and the British National Health Service.
    Pearson SD; Rawlins MD
    JAMA; 2005 Nov; 294(20):2618-22. PubMed ID: 16304076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innovation under wraps.
    Torjesen I
    Health Serv J; 2008 Feb; ():26-8. PubMed ID: 18396532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluation: an introduction.
    Raftery J
    BMJ; 1998 Mar; 316(7136):1013-4. PubMed ID: 9550969
    [No Abstract]   [Full Text] [Related]  

  • 11. Can the NICE "end-of-life premium" be given a coherent ethical justification?
    Cookson R
    J Health Polit Policy Law; 2013 Dec; 38(6):1129-48. PubMed ID: 23974470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unrelated Future Costs and Unrelated Future Benefits: Reflections on NICE Guide to the Methods of Technology Appraisal.
    Morton A; Adler AI; Bell D; Briggs A; Brouwer W; Claxton K; Craig N; Fischer A; McGregor P; van Baal P
    Health Econ; 2016 Aug; 25(8):933-8. PubMed ID: 27374115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discounting and cost-effectiveness in NICE - stepping back to sort out a confusion.
    Claxton K; Sculpher M; Culyer A; McCabe C; Briggs A; Akehurst R; Buxton M; Brazier J
    Health Econ; 2006 Jan; 15(1):1-4. PubMed ID: 16365910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating 'costs' for cost-effectiveness analysis.
    Miners A
    Pharmacoeconomics; 2008; 26(9):745-51. PubMed ID: 18767895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug prices and value for money: the Australian Pharmaceutical Benefits Scheme.
    Henry DA; Hill SR; Harris A
    JAMA; 2005 Nov; 294(20):2630-2. PubMed ID: 16304078
    [No Abstract]   [Full Text] [Related]  

  • 16. The impact of the UK NHS purchaser-provider split on the 'rational' introduction of new medical technologies.
    Rosen R; Mays N
    Health Policy; 1998 Feb; 43(2):103-23. PubMed ID: 10177613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Handling uncertainty in economic evaluations of healthcare interventions.
    Briggs AH; Gray AM
    BMJ; 1999 Sep; 319(7210):635-8. PubMed ID: 10473486
    [No Abstract]   [Full Text] [Related]  

  • 18. Economic appraisal in the British National Health Service: implications of recent developments.
    Henshall C; Drummond M
    Soc Sci Med; 1994 Jun; 38(12):1615-23. PubMed ID: 8047919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A little learning: reflections on 10 years of NICE technology appraisals.
    Longson CM
    Health Econ; 2012 Jan; 21(1):30-2. PubMed ID: 22147626
    [No Abstract]   [Full Text] [Related]  

  • 20. Aggregate Distributional Cost-Effectiveness Analysis of Health Technologies.
    Love-Koh J; Cookson R; Gutacker N; Patton T; Griffin S
    Value Health; 2019 May; 22(5):518-526. PubMed ID: 31104729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.